| | |
| Clinical data | |
|---|---|
| Trade names | Zactran |
| Other names | ML-1709460, ML-460 |
| License data | |
| Routes of administration | Subcutaneous |
| Drug class | Macrolide antibiotic |
| ATCvet code | |
| Legal status | |
| Legal status | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.123.704 |
| Chemical and physical data | |
| Formula | C40H76N2O12 |
| Molar mass | 777.050 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Gamithromycin, sold under the brand name Zactran, is a veterinary medication used for the treatment of cattle, pigs, and sheep. [3] [4] [5] It is a azalide antibacterial related to azithromycin. [3] [4] [6]
It was approved for veterinary use in the European Union in 2008. [3] [4]
In the EU, gamithromycin is indicated for the treatment and prevention of bovine respiratory disease in cattle, swine respiratory disease in pigs, and infectious pododermatitis (foot rot) in sheep. [3] [4] [6]
In the US, gamithromycin is indicated for the treatment of bovine respiratory disease in cattle. [1]